Biotechnology Mid-Cap Corcept Therapeutics Reveals Data From Hormonal Disorder Study, FDA Application Submission Expected This Quarter – Corcept Therapeutics (NASDAQ:CORT) Read more
Economic News Exclusive-India regulator moves to curb inflows into small- and mid-cap funds Read more